Current Cancer Drug Targets
Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Cancer Drug Targets, Volume 12 - Number 4
Role of Angiogenesis Inhibitors in Colorectal Cancer: Sensitive and Insensitive Tumors
, 12(4): 303 - 315L. Bagnasco, D. Piras, S. Parodi, I. Bauer, G. Zoppoli, F. Patrone and A. Ballestrero
DOI: 10.2174/156800912800190929
Patient-Tailored Treatments with Anti-EGFR Monoclonal Antibodies in Advanced Colorectal Cancer: KRAS and Beyond
, 12(4): 316 - 328A. Ballestrero, A. Garuti, G. Cirmena, I. Rocco, C. Palermo, A. Nencioni, S. Scabini, G. Zoppoli, S. Parodi and F. Patrone
DOI: 10.2174/156800912800190956
Synthetic Lethality-Based Therapeutics: Perspectives for Applications in Colorectal Cancer
, 12(4): 329 - 338D. Soncini, I. Caffa, F. Patrone, A. Ballestrero and A. Nencioni
DOI: 10.2174/156800912800190938
A Multi-Scale Approach to Colorectal Cancer: From a Biochemical- Interaction Signaling-Network Level, to Multi-Cellular Dynamics of Malignant Transformation. Interplay with Mutations and Onco-Protein Inhibitor Drugs
, 12(4): 339 - 355L. Tortolina, N. Castagnino, C. De Ambrosi, E. Moran, F. Patrone, A. Ballestrero and S. Parodi
DOI: 10.2174/156800912800190910
DNA Damage Response Pathways and Cell Cycle Checkpoints in Colorectal Cancer: Current Concepts and Future Perspectives for Targeted Treatment
, 12(4): 356 - 371S. Solier, Y. -W. Zhang, A. Ballestrero, Y. Pommier and G. Zoppoli
DOI: 10.2174/156800912800190901
Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer Drugs
, 12(4): 402 - 438J. J.G. Marin, O. Briz, M. J. Monte, A. G. Blazquez and R. I.R. Macias
DOI: 10.2174/156800912800190875
An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors
, 12(4): 439 - 452Nicola Tinari, Michele De Tursi, Antonino Grassadonia, Marinella Zilli, Liborio Stuppia, Stefano Iacobelli and Clara Natoli
DOI: 10.2174/156800912800190884
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75
Advertisement
Webmaster Contact: info@benthamscience.net